| Patent application number | Description | Published |
|---|
| 20090054427 | AMINOBENZYL-SUBSTITUTED CYCLIC SULFONES USEFUL AS BACE INHIBITORS - The invention relates to novel heterocyclic compounds of the formula | 02-26-2009 |
| 20090099207 | Cyclic sulfones useful as BACE inhibitors - The invention relates to novel heterocyclic compounds of the formula | 04-16-2009 |
| 20090143337 | C2-C5-Alkyl-Imidazole-Bisphosphonates | 06-04-2009 |
| 20090247577 | PYRROLIDINE DERIVATIVES USEFUL AS BACE INHIBITORS - Novel 3-mono-, 3,4-di- and 3,4,4,-tri-substituted pyrrolidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (disorder) that depends on the activity of beta-secretase and/or the generation of beta-amyloid and the subsequent aggregation into oligomers and fibrils; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on the activity of beta-secretase and/or the generation of beta-amyloid and the subsequent aggregation into oligomers and fibrils; pharmaceutical formulations comprising a said substituted pyrrolidine compound, and/or a method of treatment comprising administering a said substituted pyrrolidine compound. The substituted pyrrolidine compounds are especially of the formula I, | 10-01-2009 |
| 20090280131 | IL-17 Antagonistic Antibodies - An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis. | 11-12-2009 |
| 20100056490 | Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors - The invention relates to novel heterocyclic compounds of the formula | 03-04-2010 |
| 20100144741 | ETHANOLAMINE DERIVATIVES USEFUL AS BACE INHIBITORS - The invention relates to novel cyclic compounds of the formula (I), in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them. | 06-10-2010 |
| 20100215666 | IL-17 ANTAGONISTIC ANTIBODIES - An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis. | 08-26-2010 |
